Kadmon Holdings Inc KDMN:NYSE

Last Price$4.74NYSE Previous Close - Last Trade as of 6:30PM ET 12/12/19
NYSE 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$4.60 (2)
Ask (Size)$5.50 (10)
Day Low / HighN/A - N/A
Volume2.7 M

View Biotechnology IndustryPeer Comparison as of 12/12/2019


Kadmon Holdings Inc ( NYSE )

Price: $4.74
Change: -0.24 (4.82%)
Volume: 2.7 M
6:30PM ET 12/12/2019

Akebia Therapeutics Inc ( NASDAQ )

Price: $6.35
Change: +0.07 (1.11%)
Volume: 856.6 K
3:59PM ET 12/12/2019

MeiraGTx Holdings PLC ( NASDAQ )

Price: $20.52
Change: -0.04 (0.19%)
Volume: 153.4 K
3:59PM ET 12/12/2019

Cara Therapeutics Inc ( NASDAQ )

Price: $16.40
Change: +0.05 (0.31%)
Volume: 611.5 K
4:00PM ET 12/12/2019

Clovis Oncology Inc ( NASDAQ )

Price: $13.45
Change: +0.02 (0.15%)
Volume: 44.6 K
3:59PM ET 12/12/2019

Read more news Recent News

Significant Insider Buying Reverses neutral Trend over Last 90 Days in Shares of Kadmon Holdings (KDMN)
10:18PM ET 11/19/2019 MT Newswires

There was a noteworthy insider purchase in Kadmon Holdings shares today as revealed in a filing with the SEC. One insider -- Perceptive Advisors Llc,...

Insider Trends: Kadmon Holdings Sees 90 Days of Insider Selling, Trend Eased Back with Share Purchase
7:59AM ET 11/18/2019 MT Newswires

PERCEPTIVE ADVISORS LLC, Former 10% Owner, made a purchase of 1,470,588 shares in Kadmon Holdings (KDMN) for $4,999,999 on Nov 18, 2019. After the Form 4...

Kadmon Prices Public Share Sale at 4.5% Discount
4:44AM ET 11/14/2019 MT Newswires

Drug developer Kadmon (KDMN) said late Wednesday that it priced its previously announced public offering of 26 million common shares at $3.40 each, a 4.5%...

MT Newswires After-Hours News Movers
5:55PM ET 11/13/2019 MT Newswires

Some of the stocks moving on news-driven events in Wednesday's after-hours include: PING, +12.96% SNDL, +12.19% ZSAN, +10.34% PUMP, +9.67% CYCC, +9.19%...

View all Commentary and Analysis

Kadmon (KDMN) Investor Presentation - Slideshow
3:44PM ET 12/05/2019 Seeking Alpha

Tracking Dan Loeb's Third Point Portfolio - Q3 2019 Update
5:46AM ET 11/27/2019 Seeking Alpha

Daily Insider Ratings Round Up 11/18/19
3:48AM ET 11/21/2019 Seeking Alpha

NextCure's Big Rise And Fall, And Other Headlines: The Good, Bad And Ugly Of Biopharma
5:14PM ET 11/13/2019 Seeking Alpha

Company Profile

Business DescriptionKadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics. It focuses on the treatment of autoimmune, inflammatory, and fibrotic diseases. Its products include Ribasphere, RibaPak, Tetrabenazine, Valganciclovir, Abacavir, Entecavir, Lamivudine, and Zidovudine. The company was founded by Steven N. Gordon in September 2010 and is headquartered in New York, NY. View company web site for more details
Address450 East 29th Street
New York, New York 10016
Number of Employees116
Recent SEC Filing11/19/2019SC 13G
President, Chief Executive Officer & DirectorHarlan W. Waksal
Chief Financial Officer & Executive Vice PresidentSteven Meehan
Chief Medical Officer & Executive Vice PresidentJohn L. Ryan
Secretary, Chief Compliance Officer & EVPGregory S. Moss

Company Highlights

Price Open$5.05
Previous Close$4.74
52 Week Range$1.63 - 5.38
Market Capitalization$614.7 M
Shares Outstanding129.7 M
SectorHealth Technology
Next Earnings Announcement03/05/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.81
Beta vs. S&P 500N/A
Revenue$1.4 M
Net Profit Margin-9,855.14%
Return on Equity-84.25%

Analyst Ratings as of 09/04/2019

Consensus RecommendationConsensus Icon
Powered by Factset